Class 4 Medicines Defect Notification: Fexofenadine Hydrochloride 120mg film-coated tablets (Chanelle Medical Unlimited Company)
MHRA Class 4 Medicines Defect Notification: Fexofenadine Hydrochloride 120mg film-coated tablets (Chanelle Medical Unlimited Company)
Drug alert number: EL(25)A/41
Date issued: 21 August 2025
Chanelle Medical Unlimited Company has informed the MHRA of an error with the European Article Number (EAN) / Global Trade Item Number (GTIN) barcode on certain batches of Fexofenadine Hydrochloride 120mg film-coated tablets, distributed by Healthcare Pharma Limited.
DMRC reference number: DMRC – 36081293
Company name: Chanelle Medical Unlimited Company
Medicine Details
Product name: Fexofenadine Hydrochloride 120mg film-coated tablets (PL: 13931/0039)
Active ingredient: Fexofenadine Hydrochloride
SNOMED code: 14161911000001109
GTIN: 5099299199583
Affected Lot Batch Numbers
| Batch No. | Expiry Date | Pack Size | First Distributed |
| HM11123A | 28/02/2026 | 30’s | 20/09/2023 |
| HM10523 | 28/02/2026 | 30’s | 29/08/2024 |
| HM10623 | 28/02/2026 | 30’s | 19/09/2024 |
| HM10723A | 28/02/2026 | 30’s | 19/09/2024 |
| HM10823 | 28/02/2026 | 30’s | 31/10/2024 |
| HM10923 | 28/02/2026 | 30’s | 15/01/2025 |
| HM11023 | 28/02/2026 | 30’s | 31/01/2025 |
| HM11223 | 28/02/2026 | 30’s | 11/02/2025 |
| HM11323 | 28/02/2026 | 30’s | 17/02/2025 |
| HM11423 | 28/02/2026 | 30’s | 25/02/2025 |
| HM11623 | 28/02/2026 | 30’s | 25/02/2025 |
| HM11523A | 31/03/2026 | 30’s | 25/02/2025 |
| HM11723 | 31/03/2026 | 30’s | 11/03/2025 |
| HM11823 | 31/03/2026 | 30’s | 31/03/2025 |
| HM11923 | 31/03/2026 | 30’s | 02/04/2025 |
| HM12023 | 31/03/2026 | 30’s | 02/04/2025 |
| HM12123 | 31/03/2026 | 30’s | 02/04/2025 |
| HM12223 | 31/03/2026 | 30’s | 02/04/2025 |
| HM12323A | 31/03/2026 | 30’s | 02/04/2025 |
| HM12423 | 31/03/2026 | 30’s | 08/04/2025 |
| HM12523 | 31/03/2026 | 30’s | 24/04/2025 |
| HM12623 | 31/03/2026 | 30’s | 30/04/2025 |
| HM12723 | 30/04/2026 | 30’s | 16/04/2025 |
| HM12823 | 30/04/2026 | 30’s | 20/05/2025 |
| HM12923 | 30/04/2026 | 30’s | 11/06/2025 |
| HM13023 | 30/04/2026 | 30’s | 13/06/2025 |
Background
Chanelle Medical Unlimited Company has informed the MHRA of an error with the European Article Number (EAN) / Global Trade Item Number (GTIN) barcode on the cartons of the above batch of Fexofenadine Hydrochloride 120mg film-coated tablets, distributed by Healthcare Pharma Limited. When scanned, the EAN/GTIN barcode identifies the product as Naratriptan 2.5mg Tablets.
The other product details on the carton, including the name, strength and pharmaceutical form of the medicine are correct. The quality of the medicine is not impacted by the labelling defect.
Advice for healthcare professionals
Healthcare professionals are advised to use caution and consider extra safeguards for these batches in robotic or automated dispensing system or stocking systems and should carry out manual dispensing and stocking, as appropriate.
The product quality of the Fexofenadine Hydrochloride 120mg film-coated tablets is not impacted by this issue, therefore the affected batches are not being recalled.
All remaining stock of Naratriptan 2.5mg Tablets which has not been distributed from UK wholesaler will be placed on hold until April 2026 (Last expiry of impacted Fexofenadine stock) to provide further mitigation that the wrong product may be selected.
View the full alert here.
Advice for Patients
No action is needed from patients, continue to take medication from these batches as prescribed by your healthcare professional. The issue is related to the wrong barcode on the cartons of the listed batch of Fexofenadine Hydrochloride 120mg film-coated tablets and will be controlled by the healthcare professionals prescribing/dispensing the medication. The quality of the medication is not affected. Patients who experience adverse reactions or have any questions about their medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.
Additional information
For all medical information enquiries and information on this product, please contact Medical Information Department chanelle@medinformation.co.uk or telephone +44 808 304 2429 (Toll free-UK). For stock control enquiries please email David Hammond: david.hammond@healthcarepharma.co.uk.
